Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Register

Secretariat

Drafts and maintains the document set, runs the comment-period process and manages the evidence log.

Entries

10 documents
  • CEI-RG-020SecretariatDirector of the Institutesince 2023

    Responsible for the Institute's output as a whole and for the quarterly assessment cycle. She holds the final editorial decision on register language, and has consistently required that where the Institute does not know…

    Compound Evidence Institute
  • CEI-RG-023SecretariatHead of Analytical Assessmentsince 2024

    Leads the methods series and the review of submitted third-party test data. He compiled the finding, reported across the supplier dossiers, that counter-ion and water determination are absent from essentially the whole…

    Compound Evidence Institute
  • CEI-RG-026SecretariatSenior Assessment Officer, synthesessince 2024

    Drafts the evidence-synthesis series and maintains the amendment logs.

    Compound Evidence Institute
  • CEI-RG-021SecretariatHead of Secretariatsince 2023

    Manages the comment-period process, including the drafting of secretariat responses and the disposition of every submission. The convention that a submission is answered on its substance regardless of the submitter's…

    Compound Evidence Institute
  • CEI-RG-027SecretariatAssessment Officer, supplier dossierssince 2025

    Maintains the supplier dossier series, the correspondence logs and the evaluation scoring against the published rubric.

    Compound Evidence Institute
  • CEI-RG-029SecretariatRegistry and Sitemap Officersince 2025

    Maintains the document registry, the identifier series and the citation-policy implementation.

    Compound Evidence Institute
  • CEI-RG-025SecretariatSenior Assessment Officer, trial abstractssince 2024

    Maintains the structured trial-abstract series and the programme-record convention by which Institute-constructed programme instalments are labelled as such on every page on which they appear.

    Compound Evidence Institute
  • CEI-RG-022SecretariatHead of Evidence Managementsince 2023

    Maintains the reference library and the submitted-evidence log, and is responsible for the rule that a reference the Institute cannot verify against a primary record is either excluded or marked as unverified.

    Compound Evidence Institute
  • CEI-RG-028SecretariatPublications and Corrections Officersince 2024

    Maintains the corrections log and is responsible for ensuring that a correction is published on the document it corrects and not only in the log.

    Compound Evidence Institute
  • CEI-RG-024SecretariatSenior Assessment Officer, monographssince 2024

    Drafts monographs in the incretin and amylin series and maintains the per-indication evidence extracts.

    Compound Evidence Institute
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.